iSpecimen Inc. Common Stock (ISPC)
iSpecimen Inc. (ISPC) is a biotechnology company focused on providing a platform that facilitates the procurement of human biospecimens for medical research. Through its digital marketplace, the company connects researchers with a broad network of hospitals, clinics, and tissue banks to expedite the collection and delivery of quality biological samples, supporting advancements in personalized medicine and diagnostics.
Company News
iSpecimen Inc. closed a private placement of approximately $1.75 million by issuing 1,559,828 shares of common stock at $1.122 per share. The proceeds will be used for marketing services and general corporate purposes.
iSpecimen Inc. closed a $4 million public offering of 5,714,283 shares at $0.70 per share. The company plans to use proceeds for marketing services, milestone payments, and general corporate purposes.
iSpecimen Inc. announced the resignation of a director, the election of two new directors, and the approval of a reverse stock split at its annual shareholder meeting. The company also reported a decrease in revenue for Q1 2024 but highlighted a pipeline of new business opportunities.
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.